Cover Image
市場調查報告書

心房纖維顫動手術的全球市場 至2020年的預測:各治療 (心導管電氣燒灼術,手術燒灼/迷宮手術)、產品、地區

Atrial Fibrillation Surgery Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2020

出版商 MarketsandMarkets 商品編碼 346643
出版日期 內容資訊 英文 73 Pages
訂單完成後即時交付
價格
Back to Top
心房纖維顫動手術的全球市場 至2020年的預測:各治療 (心導管電氣燒灼術,手術燒灼/迷宮手術)、產品、地區 Atrial Fibrillation Surgery Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2020
出版日期: 2015年12月10日 內容資訊: 英文 73 Pages
簡介

心房纖維顫動手術的全球市場,預計2015∼2020年以11.9%的年複合成長率(CAGR) 成長。市場成長的原因之一為過去20年在全球各國心房纖維顫動的患病人數增加。2013年時,全球整體約有3億3500萬人患心房纖維顫動病,以及光是美國國內每年有20∼40萬人診斷為新的心房纖維顫動患者。現在歐洲、北美各國佔市場大半,不過,一般認為中國、印度等亞太地區也急速成長。

本報告提供全球心房纖維顫動 (AF) 治療用手術的市場相關分析、疾病&治療方法概要和主要的促進&阻礙因素、各手術儀式的市場規模&成長率趨勢和預測、主要企業簡介與業績、市場競爭環境等調查評估。

第1章 簡介

  • 分析目的
  • 前提條件與限制

第2章 分析方法

  • 心房纖維顫動 (AF) 導管與外科的治療
  • 心房纖維顫動導管及外科切除市場
  • 預測模式
  • 資料的估計方法
  • 一次受訪者簡介

第3章 心房纖維顫動導管與外科治療

  • 概要
  • 心導管電氣燒灼術治療
  • 外科的切除/迷宮手術

第4章 心房纖維顫動的手術產品市場

  • 概要
  • 心導管電氣燒灼術產品的市場
  • 外科的切除市場

第5章 競爭環境

  • 市場佔有率分析:心房纖維顫動心導管電氣燒灼術市場
  • 市場佔有率分析:心房纖維顫動手術燒灼市場
  • 競爭環境

第6章 企業簡介 (產業概要、企業概要、財務狀況、各地區/各產業的綜合收益、產品系列、主要策略、近幾年趨勢)

  • BIOSENSE WEBSTER, INC.
  • MEDTRONIC, INC.
  • ST. JUDE MEDICAL, INC.
  • BOSTON SCIENTIFIC CORPORATION
  • ATRICURE, INC.
  • CARDIOFOCUS, INC.
  • NCONTACT, INC.
  • CARIMA, INC.
  • BIOTROIK SE & CO.KG

第7章 附錄

圖表一覽

目錄
Product Code: MD 3960

The global atrial fibrillation surgery procedures market is expected to grow at a CAGR of 11.9% during the forecast period of 2015 to 2020. Over the past two decades, an increasing prevalence of atrial fibrillation cases is seen across the globe. According to American Heart Association, around 33.5 million people were suffering from atrial fibrillation around the world in 2013. Furthermore, about 200,000 to 400,000 new atrial fibrillation cases are diagnosed each year in the U.S.

This market is segmented on the basis of surgical procedures into catheter ablation and surgical ablation. Catheter and surgical ablation procedures are well accepted for the treatment of atrial fibrillation. Catheter ablation contributed to the maximum revenue in this market, in 2014. It will continue to hold dominant share in this market, growing at a CAGR of 14.5% during the forecast period of 2015 to 2020.

The geographical segmentation includes North America, Europe, Asia-Pacific and RoW. North America holds the largest share in this market, both in terms of the number of procedures and revenue. However, Asia-Pacific is expected to witness the highest growth rate due to the presence of a large patient population, increasing number of healthcare facilities, improving healthcare infrastructure, growing medical tourism, and high focus of global market players on emerging Asia-Pacific countries such as China and India. Asia-Pacific atrial fibrillation catheter ablation market is expected to grow at a higher CAGR, compared to surgical ablation market, during the forecast period.

The key driver for this market is the increasing number of people suffering from atrial fibrillation. Favorable regulatory scenario would also propel growth in this market.

A combination of top-down and bottom-up approaches were used to calculate the market sizes and growth rates of the atrial fibrillation surgery market. Secondary information was used to identify the revenues, geographical reach and product portfolio of market players. Primary interviews were conducted with the key opinion leaders to validate the revenue estimates.

The report provides qualitative insights about the key market shares, growth rates and market dynamics. It also deals with company profiles of the market leaders. It includes financial performances, product portfolios and recent developments for each company. The report provides a competitive landscape which covers all the growth strategies adopted by market players and their share in atrial fibrillation market.

Reasons to Buy the Report:

The report would facilitate established as well as new entrants to determine the pulse of the market and help them formulate strategies.

The report provides insights on the following:

  • Product Development: Product portfolios of the top players in atrial fibrillation market
  • Competitive Assessment: In-depth analysis of market shares, strategies and product portfolios of leading market players
  • Market Development: Extensive information about the lucrative emerging markets across geographies

Table of Content

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. ASSUMPTIONS & LIMITATIONS

2. RESEARCH METHODOLOGY

  • 2.1. ATRIAL FIBRILLATION CATHETER AND SURGICAL PROCEDURES
  • 2.2. ATRIAL FIBRILLATION CATHETER AND SURGICAL ABLATION MARKET
  • 2.3. FORECASTING MODEL
  • 2.4. DATA TRIANGULATION
  • 2.5. PRIMARY RESPONDENT PROFILE

3. ATRIAL FIBRILLATION CATHETER AND SURGICAL PROCEDURE

  • 3.1. OVERVIEW
  • 3.2. CATHETER ABLATION PROCEDURES
  • 3.3. SURGICAL ABLATION/MAZE PROCEDURES

4. ATRIAL FIBRILLATION SURGERY PRODUCT MARKET

  • 4.1. OVERVIEW
  • 4.2. CATHETER ABLATION PRODUCT MARKET
  • 4.3. SURGICAL ABLATION MARKET

5. COMPETITIVE LANDSCAPE

  • 5.1. MARKET SHARE ANALYSIS: AF CATHETER ABLATION MARKET, 2014
  • 5.2. MARKET SHARE ANALYSIS: AF SURGICAL ABLATION MARKET, 2014
  • 5.3. COMPETITIVE LANDSCAPE

6. COMPANY PROFILES (BUSINESS OVERVIEW, COMPANY AT GLANCE, FINANCIALS, GEOGRAPHIC REVENUE MIX, BUSINESS REVENUE MIX, PRODUCT PORTFOLIO, KEY STRATEGIES, RECENT DEVELOPMENTS)

  • 6.1. BIOSENSE WEBSTER, INC.
  • 6.2. MEDTRONIC, INC.
  • 6.3. ST. JUDE MEDICAL, INC.
  • 6.4. BOSTON SCIENTIFIC CORPORATION
  • 6.5. ATRICURE, INC.
  • 6.6. CARDIOFOCUS, INC.
  • 6.7. NCONTACT, INC.
  • 6.8. CARIMA, INC.
  • 6.9. BIOTROIK SE & CO.KG

7. APPENDIX

  • 7.1. ADDITIONAL INSIGHTS
  • 7.2. SECONDARY RESOURCES
  • 7.3. RELATED REPORTS

List of Tables

  • TABLE 1: ATRIAL FIBRILLATION SURGICAL PROCEDURES, BY TYPE OF PROCEDURE (NUMBER OF PROCEDURES)
  • TABLE 2: ATRIAL FIBRILLATION CATHETER ABLATION PROCEDURES, BY REGION (NUMBER OF PROCEDURES)
  • TABLE 3: NORTH AMERICA: ATRIAL FIBRILLATION CATHETER ABLATION PROCEDURES, BY COUNTRY (NUMBER OF PROCEDURES)
  • TABLE 4: EUROPE: ATRIAL FIBRILLATION CATHETER ABLATION PROCEDURES, BY COUNTRY (NUMBER OF PROCEDURES)
  • TABLE 5: ASIA-PACIFIC: ATRIAL FIBRILLATION CATHETER ABLATION PROCEDURES, BY COUNTRY (NUMBER OF PROCEDURES)
  • TABLE 6: ATRIAL FIBRILLATION SURGICAL ABLATION/MAZE PROCEDURES, BY REGION (NUMBER OF PROCEDURES)
  • TABLE 7: NORTH AMERICA: ATRIAL FIBRILLATION SURGICAL ABLATION/MAZE PROCEDURES, BY COUNTRY (NUMBER OF PROCEDURES)
  • TABLE 8: EUROPE: ATRIAL FIBRILLATION SURGICAL ABLATION/MAZE PROCEDURES, BY COUNTRY (NUMBER OF PROCEDURES)
  • TABLE 9: ASIA-PACIFIC: ATRIAL FIBRILLATION SURGICAL ABLATION/MAZE PROCEDURES, BY COUNTRY (NUMBER OF PROCEDURES)
  • TABLE 10: ATRIAL FIBRILLATION SURGERY PRODUCT MARKET, BY TYPE OF PROCEDURE ($ MILLION)
  • TABLE 11: GLOBAL ATRIAL FIBRILLATION CATHETER ABLATION PRODUCT MARKET, BY REGION ($ MILLION)
  • TABLE 12: NORTH AMERICA: ATRIAL FIBRILLATION CATHETER ABLATION PRODUCT MARKET, BY COUNTRY ($ MILLION)
  • TABLE 13: EUROPE: ATRIAL FIBRILLATION CATHETER ABLATION PRODUCT MARKET, BY COUNTRY ($ MILLION)
  • TABLE 14: ASIA-PACIFIC: ATRIAL FIBRILLATION CATHETER ABLATION PRODUCT MARKET, BY COUNTRY ($ MILLION)
  • TABLE 15: ATRIAL FIBRILLATION SURGICAL ABLATION PRODUCT MARKET, BY REGION ($ MILLION)
  • TABLE 16: NORTH AMERICA: ATRIAL FIBRILLATION SURGICAL ABLATION PRODUCT MARKET, BY COUNTRY ($ MILLION)
  • TABLE 17: EUROPE: ATRIAL FIBRILLATION SURGICAL ABLATION PRODUCT MARKET, BY COUNTRY ($ MILLION)
  • TABLE 18: ASIA-PACIFIC: ATRIAL FIBRILLATION SURGICAL ABLATION PRODUCT MARKET, BY COUNTRY ($ MILLION)
Back to Top